Alcon “Hawk” AMD RTH-258-C001

Completed Studies

A two-year, randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the efficacy and safety of RTH258 versus Aflibercept in subjects with Neovascular Age-Related Macular Degeneration.

Duration: 96 Weeks

This entry was posted in Uncategorized. Bookmark the permalink.